Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2018-07-26 2017-03-13
Drug Identification Number 02264927 02264927
Brand name EPIRUBICIN HYDROCHLORIDE INJECTION EPIRUBICIN HYDROCHLORIDE INJECTION
Common or Proper name EPIRUBICIN EPIRUBICIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients EPIRUBICIN HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10mg/5mL x 1 10mg/5mL x 1
ATC code L01DB L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2014-10-14 2014-10-14
Actual start date 2014-11-29 2014-11-29
Estimated end date Unknown Unknown
Actual end date 2017-09-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments It has been discontinued (report ID 15441)
Health Canada comments